MedTrace Logo

Long Study - Longitudinal Thrombosis in End Stage Renal Disease

NCT00157664 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2008-06-17

No results posted yet for this study

Summary

The primary focus of this study is to collect information through diagnostic testing, blood sample analysis and patient data collection on patients starting hemodialysis to determine risk and preventative factors of bleeding and clotting events.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Alistair J Ingram, MD · Associate Professor, Medicine

  • Catherine M Clase, MD · Associate Professor, Medicine

  • Mark A Crowther, MD · Associate Professor, Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2008-05-31
Completion
2008-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157664 on ClinicalTrials.gov